Olmez, O. F. Et Al. 2023. Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.. Pulmonology , vol.29, no.6 , 478-485.

Olmez, O. F., Bilici, A., Gursoy, P., Cubukcu, E., Sakin, A., Korkmaz, T., ... Cil, I.(2023). Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.. Pulmonology , vol.29, no.6, 478-485.

Olmez, O Et Al. "Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.," Pulmonology , vol.29, no.6, 478-485, 2023

Olmez, O F. Et Al. "Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.." Pulmonology , vol.29, no.6, pp.478-485, 2023

Olmez, O. F. Et Al. (2023) . "Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.." Pulmonology , vol.29, no.6, pp.478-485.

@article{article, author={O F Olmez Et Al. }, title={Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.}, journal={Pulmonology}, year=2023, pages={478-485} }